Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its… Nov 30, 2021
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical… Nov 30, 2021
Catching Up With PharmaDrug CEO Daniel Cohen On COVID-19 Treatments And Psychedelic Research Strategy Nov 23, 2021
Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection… Nov 16, 2021
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Oct 26, 2021
PharmaDrug Announces pre-IND Meeting Request Granted by FDA for Oral Antiviral Drug Cepharanthine for the Treatment of… Sep 28, 2021
